Stress and A1c Among People with Diabetes Across the Lifespan
- PMID: 27287017
- PMCID: PMC4936828
- DOI: 10.1007/s11892-016-0761-3
Stress and A1c Among People with Diabetes Across the Lifespan
Abstract
Stress is known to negatively affect health and is a potentially serious barrier to diabetes-related health outcomes. This paper synthesizes what is known about stress and glycemic control among people with type 1 and type 2 diabetes across the lifespan. Chronic stress-especially in relation to living with diabetes-was most strongly associated with A1c, particularly among subgroups that face disproportionate stress, such as minority groups or adolescents/young adults. Mechanisms of the stress-A1c association include physiological, psychological, behavioral, and environmental links. Understanding the dimensions of stress as they relate to health in diabetes can be of significant clinical importance, and interventions targeting mechanisms that either exacerbate or buffer stress have reported modest improvements in A1c.
Keywords: Glycemic control; Stress; Type 1 diabetes; Type 2 diabetes.
Figures
References
-
- Geiss LS, Wang J, Cheng YJ, et al. Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980-2012. JAMA. 2014;312:1218–26. - PubMed
-
- American Diabetes Association Standards of medical care in diabetes—2016. Diabetes Care. 2016;39(1):S1–S112. - PubMed
-
- Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–86. - PubMed
-
- Diabetes Control and Complications Trial Study Group The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes. 1995;44:968–83. - PubMed
-
- UK Prospective Diabetes Study (UKPDS) Group Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet. 1998;352:837–53. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
